Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3731 3734 3752 3771 3773 3774
This examiner grants 68% of resolved cases
Melanie Ruano Tyson has resolved 820 cases in Tech Center 3700 and Art Unit 3731. The examiner's allowance rate is 68.4%, and the median days to allowance is 1327. The interview lift is 18.9%, showing that interviews are a beneficial tactic for increasing the likelihood of a grant.
With 820 resolved cases, the 68.4% allowance rate is a stable and reliable figure. The 18.9% lift is a significant enough increase to justify the time and expense of an interview. Practitioners should be aware of the 1327-day median, which indicates a longer prosecution period. Using the 18.9% lift early might help in navigating the 1327-day timeline more efficiently. The data from 820 resolutions suggests that the examiner is open to discussion. Applicants should prepare for a thorough process in Art Unit 3731.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18535347 | STENT WITH SELF-ADJUSTING ANTI-MIGRATION FEATURES | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 18164530 | STENT INCLUDING ANTI-MIGRATION MEMBERS | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18007918 | NANOFIBER CARDIAC PATCH AND METHODS OF USE THEREOF | Non-Final OA | Ohio State Innovation Foundation |
| 18617773 | DELIVERY SYSTEM INCLUDING A SPLIT CAPSULE | Non-Final OA | Medtronic, Inc. |
| 17816301 | CORONARY COVERED STENT | Final Rejection | Merit Medical Systems, Inc. |
| 18189160 | Apparatus and Method for Transcardiac Valve Delivery | Non-Final OA | ConneX BioMedical, Inc. |
| 18531802 | ENGINEERED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME | Non-Final OA | Axogen Corporation |
| 18051353 | TISSUE WRAP DEVICE WITH ATTACHMENT FEATURES | Non-Final OA | Axogen Corporation |
| 18280882 | Intraocular Lenses for Reducing Peripheral Pseudophakic Dysphotopsia | Final Rejection | Brien Holden Vision Institute Limited |
| 18392344 | TRANSCATHETER DEVICE FOR TREATING TRICUSPID VALVE REGURGITATION | Non-Final OA | TAU MEDICAL INC. |
| 18687907 | STEERABLE CATHETER SYSTEM | Non-Final OA | Endoron Medical Ltd. |
| 17663180 | PROSTHETIC CAPSULAR DEVICES, SYSTEMS, AND METHODS | Final Rejection | Omega Ophthalmics LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy